Store depletion by caffeine/ryanodine activates capacitative Ca(2+) entry in nonexcitable A549 cells.
Capacitative Ca(2+) entry is essential for refilling intracellular Ca(2+) stores and is thought to be regulated primarily by inositol 1, 4,5-trisphosphate (IP(3))-sensitive stores in nonexcitable cells. In nonexcitable A549 cells, the application of caffeine or ryanodine induces Ca(2+) release in the absence of extracellular Ca(2+) similar to that induced by thapsigargin (Tg), and Ca(2+) entry occurs upon the readdition of extracellular Ca(2+). The channels thus activated are also permeable to Mn(2+). The channels responsible for this effect appear to be activated by the depletion of caffeine/ryanodine-sensitive stores per se, as evidenced by the activation even in the absence of increased intracellular Ca(2+) concentration. Tg pretreatment abrogates the response to caffeine/ryanodine, whereas Tg application subsequent to caffeine/ryanodine treatment induces further Ca(2+) release. The response to caffeine/ryanodine is also abolished by initial ATP application, whereas ATP added subsequent to caffeine/ryanodine induces additional Ca(2+) release. RT-PCR analyses showed the expression of a type 1 ryanodine receptor, two human homologues of transient receptor potential protein (hTrp1 and hTrp6), as well as all three types of the IP(3) receptor. These results suggest that in A549 cells, (i) capacitative Ca(2+) entry can also be regulated by caffeine/ryanodine-sensitive stores, and (ii) the RyR-gated stores interact functionally with those sensitive to IP(3), probably via Ca(2+)-induced Ca(2+) release.
First Department of Biochemistry, and Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Handa-cho, Hamamatsu, Shizuoka 431-3192, Japan. xueh@nhlbi.nih.gov
H H
HH
Xue
D M
DM
Zhao
T
T
Suda
C
C
Uchida
T
T
Oda
K
K
Chida
A
A
Ichiyama
H
H
Nakamura
D002110:Caffeine / Q000494:pharmacology*; D002118:Calcium / Q000378:metabolism* / Q000502:physiology; D015220:Calcium Channels / Q000378:metabolism; D002135:Calcium-Binding Proteins; D004268:DNA-Binding Proteins / Q000378:metabolism*; D005656:Fungal Proteins / Q000378:metabolism; D006801:Humans; D008840:Microfilament Proteins; D020033:Protein Isoforms / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012433:Ryanodine / Q000494:pharmacology*; D019837:Ryanodine Receptor Calcium Release Channel / Q000378:metabolism*; D050052:TRPC Cation Channels; D019284:Thapsigargin / Q000494:pharmacology; D014407:Tumor Cells, Cultured
C112986:AIF1 protein, human; D015220:Calcium Channels; D002135:Calcium-Binding Proteins; D004268:DNA-Binding Proteins; D005656:Fungal Proteins; D008840:Microfilament Proteins; D020033:Protein Isoforms; D019837:Ryanodine Receptor Calcium Release Channel; D050052:TRPC Cation Channels; C096351:transient receptor potential cation channel, subfamily C, member 1; D012433:Ryanodine; D002110:Caffeine; D019284:Thapsigargin; D002118:Calcium